Trials / Conditions / Safety and Efficacy

Safety and Efficacy

23 registered clinical trials studyying Safety and Efficacy — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	RIG 101 Trial in Healthy Adults and Adults With Asthma NCT07488897	RIGImmune Inc.	Phase 1 / Phase 2
Not Yet Recruiting	A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease NCT07085195	Ruijin Hospital	EARLY_Phase 1
Recruiting	Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars NCT06751433	Herbarium Laboratorio Botanico Ltda	Phase 1 / Phase 2
Recruiting	Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Ca NCT06244537	Sichuan Cancer Hospital and Research Institute	N/A
Active Not Recruiting	Safety and Efficacy of CD19 CAR-T/CAR-NK Cells NCT06596057	The Second Hospital of Shandong University	EARLY_Phase 1
Unknown	Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involve NCT06066840	The First Affiliated Hospital of Soochow University	Phase 4
Recruiting	Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites NCT05349552	Peking University Third Hospital	—
Recruiting	Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block NCT05556889	Tongji Hospital	N/A
Unknown	Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH NCT05008666	Sun Yat-sen University	Phase 2
Terminated	NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT05247957	Hangzhou Cheetah Cell Therapeutics Co., Ltd	N/A
Unknown	Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL NCT04994210	Sun Yat-sen University	Phase 2
Unknown	Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD NCT05140616	The First Affiliated Hospital of Soochow University	Phase 1 / Phase 2
Unknown	A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells) NCT04852068	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	Phase 3
Completed	Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals NCT04785170	Vedic Lifesciences Pvt. Ltd.	N/A
Unknown	A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 NCT04646590	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	Phase 3
Unknown	Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD NCT05021276	The First Affiliated Hospital of Soochow University	Phase 4
Unknown	Dose Exploration Study OF JWCAR129, BCMA-Targeted CART for RRMM NCT04677452	The First Affiliated Hospital of Soochow University	Phase 1
Completed	Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients NCT04621123	Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia	Phase 2
Unknown	Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia NCT04446806	The First Affiliated Hospital of Soochow University	Phase 4
Completed	Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL NCT03820596	Huiqiang Huang	Phase 1 / Phase 2
Active Not Recruiting	Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT NCT03455972	The First Affiliated Hospital of Soochow University	Phase 1 / Phase 2
Completed	Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) NCT02018250	U.S. Army Medical Research and Development Command	Phase 1
Completed	The HEALS Project - Health Education and Active Living for Surviving Seniors NCT01305044	University of Utah	Phase 2